Tauranga, New Zealand--By almost all parameters measured, the efficacy of holmium laser transurethral procedures in the prostate match or exceed that of similar open and transurethral procedures, according to a significant body of work by Peter J. Gilling, MD, urologic consultant at Tauranga Hospital, New Zealand. Dr. Gilling's research has centered on two procedures'holmium laser resection of the prostate (HoLRP) and holmium laser enucleation of the prostate (HoLEP)-although HoLRP has essentially been replaced by the 100-watt HoLEP (Lumenis, Santa Clara, CA).
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.